Delivery Order SPE2DB22D2211-SPE2DB25FRRCH

Award Date 2/11/25
Potential Completion Date 2/12/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,929.49, is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a medical product. The contract has a firm fixed-price pricing type and an ultimate completion date of January 16, 2025. This order is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,257.52, is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of November 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a medical supply, with a ceiling value of $5,285.86 and a completion date of January 9, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a medical product, with a ceiling value of $15,296.78 and an ultimate completion date of November 19, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a ceiling value of $5,260 and an ultimate completion date of October 31, 2024. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. AmerisourceBergen...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,649.04, is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of November 6, 2024. There is no set-aside designation for this award. AmerisourceBergen holds a larger Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $6,117.18 and an ultimate completion date of May 20, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,943.05 firm fixed-price contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a medical product, with a period of performance through May 31, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $15,640.62 and a completion date of May 8, 2024. It is a firm fixed-price contract, without any set-aside designation. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $16,257.11 and a period of performance through May 23, 2024. The award is for the supply of the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB25FRRCH
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the medical product "MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML" and has a ceiling value of $12,516.14. The contract is a firm fixed-price delivery order with a completion date of February 12, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award reviewed was not designated with any set-aside requirements, indicating open competition.

Generated 5/13/25, 9:56 AM